Valero Energy (VLO): A Refining Giant With Earnings Momentum and Global Reach
Valero Energy Corp (NYSE:VLO) is among the best oil & gas refinery stocks to buy now. On February 13, Reuters reported that Valero Energy Corp (NYSE:VLO) was set to import up to 6.5 million barrels of crude from Venezuela in March. The report further said Valero would process the crude at its Gulf Coast refineries.
In its Q4 2025 earnings report released on January 29, Valero posted results that surpassed consensus expectations. EPS of $3.82 exceeded the $3.11 that was forecast. Revenue of $30.4 billion also surpassed the expected $29 billion. In the company’s refining business, operating income soared to $1.7 billion from $437 million in the same quarter in 2024.
The quarter was bolstered by improvements in margins throughput volumes. Valero ended 2025 with $4.7 billion in cash and cash equivalents. The company returned $1.4 billion in cash to shareholders in Q4 2025 and $4 billion in the full-year 2025.
Following Valero’s solid Q4 results, Citi analyst Vikram Bagri boosted the firm’s price target on Valero stock to $212 from $190 while maintaining a Neutral rating.
Valero Energy Corp (NYSE:VLO) is a multinational manufacturer and marketer of fuels and petrochemical products. The company has a portfolio of 15 refineries across the US, Canada, and the UK. Its refining capacity is about 3.2 million barrels per day. Valero has a stake in Diamond Green Diesel Holdings, a joint venture that produces low-carbon fuels.
While we acknowledge the potential of VLO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Angel Oak: Fourth Quarter Financial Results Overview
Resuming the Keystone XL Oil Pipeline Could Spark Renewed Debate

Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference

